Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Regulatory News (UPR)

Share Price Information for Uniphar (UPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 223.00
Bid: 220.00
Ask: 226.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.727%)
Open: 223.00
High: 223.00
Low: 223.00
Prev. Close: 223.00
UPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results

11 May 2023 15:32

RNS Number : 1538Z
Uniphar PLC
11 May 2023
 

AGM Results

 

Dublin, London | 11 May 2023

 

 

Uniphar plc (the Company) is pleased to announce that at its Annual General Meeting held at 11.00 a.m. today, 11 May 2023, each of the resolutions set out in the Notice of Annual General Meeting circulated to shareholders and made available on the Company's website, www.uniphar.ie, were duly passed without amendment.

 

Details of votes cast are set out below:

 

 

 

RESOLUTION

For

For %

Against

Against

%

Withheld

1

Financial Statements and Reports

152,222,114

100.00%

-

0.00%

122,760

2

Final Dividend of €3.1m

152,344,874

100.00%

-

0.00%

-

3(a)

Re-elect Ger Rabbette

143,343,970

94.10%

8,983,856

5.90%

-

3(b)

Re-elect Tim Dolphin

151,670,590

99.58%

646,008

0.42%

28,276

3(c)

Re-elect Paul Hogan

126,308,788

91.68%

11,470,073

8.32%

14,566,013

3(d)

Re-elect Sue Webb

145,057,596

95.22%

7,287,278

4.78%

-

3(e)

Re-elect Jeff Berkowitz

135,359,924

88.85%

16,984,950

11.15%

-

3(f)

Re-elect Jim Gaul

143,367,303

94.11%

8,977,571

5.89%

-

3(g)

Re-elect Liz Hoctor

145,145,135

95.27%

7,199,739

4.73%

-

3(h)

Re-elect Maurice Pratt

146,755,320

97.96%

3,053,597

2.04%

2,535,957

4

Remuneration of Auditors*

101,192,290

67.55%

48,616,627

32.45%

2,535,957

5

Allot relevant securities

139,001,133

91.24%

13,343,741

8.76%

-

6

Disapplication of pre-emption rights in specified circumstances

151,875,721

99.78%

334,459

0.22%

128,941

7

Disapplication of pre-emption rights in additional circumstances

135,251,268

88.84%

16,992,560

11.16%

101,046

8

Authorise market purchases of the Company's Ordinary Shares

151,780,712

100.00%

-

0.00%

564,162

9

Re-issuance of Treasury Shares

152,344,874

100.00%

-

0.00%

-

10

Amendment of the Company's Articles of Association to provide for electronic communications

152,311,226

100.00%

-

0.00%

33,648

 

 

\* The Board notes that Resolution 4 passed with a majority of less than 80% (receiving votes in favour of 67.55%). In accordance with provision 4 of the UK Corporate Governance Code (the "Code"), the Board confirms that it will engage with shareholders to understand and discuss the reasons behind the votes received against this resolution. An update on the views received from shareholders and actions taken will be provided within six months of the Annual General Meeting, in accordance with the Code.

 

 

--- ENDS ---

 

 

For further details contact:

 

Uniphar Group

 

Tel: +353 (0) 1 428 7777

Allan Smylie, Head of Strategy and IR

Davy (Joint Corporate Broker, Nominated Advisor and

Euronext Growth Listing Sponsor)

 

Tel: +353 (0) 1 679 6363

Daragh O'Reilly

Niall Gilchrist

Ivan Murphy

RBC Capital Markets (Joint Corporate Broker)

 

Tel: +44 (0) 20 7653 4000

Jonathan Hardy

Jamil Miah

Stifel Nicolaus Europe Limited (Joint Corporate Broker)

 

Tel: +44 (0) 20 7710 7600

Matt Blawat

Ben Maddison

Francis North

Q4 PR

 

Tel: +353 (0) 1 475 1444

Iarla Mongey, Public Relations Advisor to Uniphar Group

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKDBNQBKDDPD
Date   Source Headline
26th Apr 20241:48 pmRNSHolding(s) in Company
15th Apr 20249:00 amRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSNotice of AGM & Annual Report
27th Feb 20247:00 amRNS2023 Preliminary Results
6th Feb 202410:30 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20247:00 amRNSDirectorate Change
24th Nov 202311:20 amRNSHolding(s) in Company
9th Oct 202311:00 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20233:33 pmRNSHolding(s) in Company
19th Sep 20239:29 amRNSHolding(s) in Company
14th Sep 20233:00 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNS2023 Interim Results
4th Sep 20237:00 amRNSHolding(s) in Company
1st Aug 20232:45 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
14th Jun 20235:00 pmRNSHolding(s) in Company
11th May 20233:32 pmRNSAGM Results
11th May 20237:00 amRNSAGM Statement
3rd May 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSNotice of AGM & Annual Report & Dividend Update
3rd Mar 20237:00 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNS2022 Preliminary Results
3rd Feb 20237:00 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSCompletion of McCauley Acquisition
31st Jan 20237:00 amRNSFull Year Trading Update and Notice of Results
25th Jan 20237:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSNavi acquisition not cleared by CCPC
8th Dec 20224:06 pmRNSHolding(s) in Company
2nd Dec 20227:00 amRNSNew Share Option Plan
21st Nov 20227:00 amRNSAcquisition of BModesto Group
4th Oct 20227:00 amRNSAcquisition of healthcare agency Inspired Health
19th Sep 20227:00 amRNSAcquisition of McCauley Pharmacy Group
14th Sep 20229:08 amRNSDirector/PDMR Shareholding
30th Aug 20227:00 amRNS2022 Interim Results
26th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
11th May 20224:16 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
7th Apr 20227:00 amRNSNotice of AGM & Annual Report
3rd Mar 20227:31 amRNSDirector/PDMR Shareholding
3rd Mar 20227:29 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20227:00 amRNS2021 Preliminary Results
21st Feb 20228:00 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSFull Year Trading Update & Notice of Results
23rd Dec 20217:00 amRNSAcquisitions of E4H, Devonshire and Navi Group
17th Dec 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.